Climate-related financial disclosures of the BCL's non-monetary policy portfolios ... The BCL's role in European and international fora on climate change 7 ... This year, the BCL has broadened the scope of this report by including scope 3 emissions.
6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that its proprietary novel Bcl-2 selective ...
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL... The introduction of Bcl-2 inhibitors has further revolutionized the treatment of CLL/SLL.
BCL...MAS Services Limited, the Registrar and ShareTransferAgent (RTA) of BCL Enterprises Limited ("the Company") for the Quarter ended as on 30th June, 2025 ... Thanking you For BCL Enterprises Limited ... BCL Enterprises Limited.
_ 3 July 2025_ bcl-admin_ 0 Comments ...BCL outlined the need for safe site access to carry out early-stage exploration activities under its existing EL01 exploration licence ... Author bcl-admin.
This transfer, valued at approximately NZ$56 million at current market rates, is expected to be formally announced by Prime MinisterJames Marape on Thursday ... .
) The BCL is a partner in the national campaign against online fraud ... The BCL is represented by Mr Nicolas Weber, Director. By actively participating in this national information campaign, the BCL is ...
TEHRAN – DJ Newbill showed nerves of steel in the endgame to lift Japanese club Utsunomiya past Tabiat of Iran in double overtime, 94-93, to reach the BCLAsia 2025 Semi-Finals at the Coca-Cola Arena, Wednesday ... .